3:24 PM
 | 
Nov 07, 2018
 |  BC Extra  |  Company News

Management tracks: Myovant, Alkahest

Women’s health and endocrine disease company Myovant Sciences Ltd. (NYSE:MYOV) named Kim Sablich chief commercial officer and Jeff Nornhold SVP of pharmaceutical operations and development. Sablich was VP of primary care marketing in the U.S. for GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), and Nornhold was SVP of technical operations for Impax Laboratories Inc. Impax merged with Amneal Pharmaceuticals LLC in May...

Read the full 271 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >